It means that larger companies and investors will take BMSN more seriously. This means that it'll be easier to attract the investors needed or to do a "Joint Venture" with larger Biopharms for their trials.
Basically, OTC Pink vs OTC QB is kind of like a mini version of NASDAQ vs OTC.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.